References
- L. J. Appel et al. (2003). Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA, 289(16), 2083-2093. DOI: 10.1001/jama.289.16.2083.
- P. J. Elmer et al. (2006). Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med., 144(7), 485-495. DOI: 10.7326/0003-4819-144-7-200604040-00007
- J. R. Emberson, A. G. Shaper, S. G. Wannamethee, R. W. Morris & P. H. Whincup. (2005). Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Am J Epidemiol, 161(9), 856-863. DOI: 10.1093/aje/kwi111
- H. Lee et al. (2010). Factors associated with control of blood pressure among elderly people diagnosed with hypertension in a rural area of South Korea: the Chungju Metabolic Disease Cohort Study (CMC study). Blood Press, 19(1), 31-39. DOI: 10.3109/08037050903424117
- W. Motz & B. E. Strauer. (1994). Benefits and risks of hypertension therapy from the cardiac viewpoint. Review Z Kardiol, 83(3), 179-187.
- L. Abenavoli, R. Capasso, N. Milic & Capasso, F. (2010). Milk thistle in liver diseases: past, present, future. Phytotherapy Research, 24, 1423-1432. DOI: 10.1002/ptr.3207
- S. Cufi et al. (2013). Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Food and Chemical Toxicology, 60, 360-368. DOI: 10.1016/j.fct.2013.07.063
- A. P. Somlyo & A. V. Somlyo. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236. DOI: 10.1038/372231a0
- A. P. Somlyo & A. V. Somlyo. (1998). From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiologica Scandinavica, 164, 437-448. DOI: 10.1046/j.1365-201X.1998.00454.x
- M. Uehata et al. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature, 389, 990-994. DOI: 10.1038/40187
- S. Sakurada et al. (2003). Ca2+-dependent activation of Rho and Rho-kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circulation Research, 93, 548-556. DOI : 10.1161/01.RES.0000090998.08629.60
- T. Kitazawa, M. Masuo & A. P. Somlyo. (1991). G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proceedings of National Academy of Sciences of USA, 88, 9307-9310.
- A. Gohla, G. Schultz & S. Offermanns. (2000). Roles for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circulation Research, 87, 221-227. DOI : 10.1161/01.res.87.3.221
- T. Leung, E. Manser, L. Tan & L. Lim. (1995). A novel serine/threonine kinase binding the Rasrelated RhoA GTPase which translocates the kinase to peripheral membranes. The Journal of Biological Chemistry, 270(49), 29051-29054. DOI : 10.1074/jbc.270.49.29051
- T. Matsui et al. (1996). Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. The EMBO Journal, 15, 2208-2216. PMID: 8641286 https://doi.org/10.1002/j.1460-2075.1996.tb00574.x
- W. G. Wier & K. G. Morgan. (2003). Alpha1- adrenergic signaling mechanisms in contraction of resistance arteries. Reviews of Physiology, Biochemistry and Pharmacology, 150, 91-139. DOI : 10.1007/s10254-003-0019-8
- J. D. Clark et al (1997). The 1996 guide for the care and use of laboratory animals. ILAR journal, 38(1), 41-48. DOI : 10.1093/ilar.38.1.41
- S. Cufi et al. (2013). Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Food Chem Toxicol, 60, 360-368. DOI : 10.1016/j.fct.2013.07.063
- S. B. Jeon et al (2006). A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochemical and Biophysical Research Communications, 343(1), 27-33. PMID: 16527249 https://doi.org/10.1016/j.bbrc.2006.02.120